Tuesday June 21, 2022

11:30 amSector Analysis

Ophthalmology

Ophthalmology continues to be a big area of investor interest with considerable scope for consolidation. Governments are increasingly outsourcing cataract operations and the sector is starting to unlock the potential for multifocal lens in middle age. We’ll explore how businesses are increasing their value in the drive for profit growth.

Speakers include:

Tim Clover, CEO, Rayner

Peter Byloos, CEO, Optegra

Ulla Napankangas, CEO, Coronaria Eye Health

Moderated by: Tobias Koesters, Partner, L.E.K. Consulting

Tim CloverCEORayner

Peter ByloosCEOOptegra

Ulla NapankangasCEOCoronaria Eye Health

Tobias KoestersPartnerL.E.K. Consulting

St James - 4th Floor

Explore similar sessions

9:00 amInvestment M&A

2022 Health Care M&A Landscape

2021 has been a record year for deal activity and IPOs. But as multiples hit a ceiling, what will happen in 2022? Investors are keeping a watchful eye on inflation,...

Fleming - 3rd Floor

Hedley GoldbergPartnerRothschild & Co

4:00 pmSector Analysis

Mental Health

Covid has created huge extra demand for mental health services. How far can this be met by digital therapeutics and how can operators consolidate this fragmented sector? And how far...

Whittle - 3rd Floor

Kate NewhouseChief Operating Officer & Executive DirectorKooth Plc

Alexis GrandDeputy CEOInicea

Dr Adrienne RivlinPartnerL.E.K. Consulting

Martin Debenito GellnerSenior AnalystHealthcare Business International

3:00 pmSector Analysis

Primary Care PLUS

The huge primary care sector in Europe holds the key to outpatient consolidation. Here we look at how operators are pairing it with digital and telehealth, pharmacies and imaging. And...

Whittle - 3rd Floor